Merge Engages New York Investment Bank to Explore, Assess Strategic Options

By MedImaging International staff writers
Posted on 11 Sep 2012
Merge Healthcare, Inc. (Chicago, IL, USA), a leading provider of clinical systems, announced that its board of directors has retained Allen & Company, LLC (New York, NY, USA) investment bank, to help in investigating and evaluating a wide range of strategic alternatives, including (but not limited to), a sale of the company or a business combination.

Merge does not have a distinct timeline for the strategic review, and there is no guarantee that the review will result in any specific action or transaction. Company spokespersons stated that they are not commenting further regarding the evaluation of strategic alternatives, unless a definitive agreement for a specific transaction is entered into, the process is concluded, or it otherwise considers additional disclosure is suitable or required.

Merge’s enterprise and cloud-based solutions for image-intensive specialties provide access to any image, anywhere, any time. Moreover, Merge develops health stations, clinical trials software, and other health data and analytics systems that engage consumers in their personal health.

Related Links:

Merge
Allen & Company




Latest Industry News News